| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6063345 | Journal of Allergy and Clinical Immunology | 2015 | 7 Pages |
Abstract
Anakinra effectively reduced airway neutrophilic inflammation and resulted in no serious adverse events in a model of inhaled LPS challenge. Anakinra is a potential therapeutic candidate for treatment of asthma with neutrophil predominance in diseased populations.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Michelle L. MD, Katherine BA, Martha RRT, Krista MD, Maria M. PhD, Hongtao BS, Haibo PhD, David B. MD, MS,